News Third fire at Novo Nordisk, but company says there’s no link Danish drugmaker Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.
News Second fire at Novo Nordisk in a week now under control Firefighters have been able to extinguish a fire that raged through an office building at the site of Novo Nordisk’s headquarters in Denmark, although it will not survive
News Dismay but little surprise as NICE rejects Alzheimer's drugs Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face